Matches in Nanopublications for { ?s ?p "[LMO1 is a novel oncogene in colorectal cancer and its overexpression is a new predictive marker for anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[LMO1 is a novel oncogene in colorectal cancer and its overexpression is a new predictive marker for anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[LMO1 is a novel oncogene in colorectal cancer and its overexpression is a new predictive marker for anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[LMO1 is a novel oncogene in colorectal cancer and its overexpression is a new predictive marker for anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[LMO1 is a novel oncogene in colorectal cancer and its overexpression is a new predictive marker for anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1184072.RActGc3vcNe6nkOf6OVxCHaIgOQa7WJ2WRJHOabISvgOE130_assertion description "[LMO1 is a novel oncogene in colorectal cancer and its overexpression is a new predictive marker for anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1184072.RActGc3vcNe6nkOf6OVxCHaIgOQa7WJ2WRJHOabISvgOE130_provenance.
- NP1184069.RAjZ1Gi_7gI0lMgYNy6KV_fTVsCCinzx6f-pFNC7sDPNQ130_assertion description "[LMO1 is a novel oncogene in colorectal cancer and its overexpression is a new predictive marker for anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1184069.RAjZ1Gi_7gI0lMgYNy6KV_fTVsCCinzx6f-pFNC7sDPNQ130_provenance.
- NP1184073.RAjn6UPj_0HIvg32NMUu6xcOxV2vsBv1x0M0kxiCHmIgc130_assertion description "[LMO1 is a novel oncogene in colorectal cancer and its overexpression is a new predictive marker for anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1184073.RAjn6UPj_0HIvg32NMUu6xcOxV2vsBv1x0M0kxiCHmIgc130_provenance.
- NP538000.RA4YxrYEfjUPx6lQK-4gls5aw1RKgVxv3oTq3hxUGgCcQ130_assertion description "[LMO1 is a novel oncogene in colorectal cancer and its overexpression is a new predictive marker for anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538000.RA4YxrYEfjUPx6lQK-4gls5aw1RKgVxv3oTq3hxUGgCcQ130_provenance.
- NP537975.RAHve3DV-jiqx5Nwu7LFuU5vE9xtcOwPkKQfUKwMeNbN4130_assertion description "[LMO1 is a novel oncogene in colorectal cancer and its overexpression is a new predictive marker for anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537975.RAHve3DV-jiqx5Nwu7LFuU5vE9xtcOwPkKQfUKwMeNbN4130_provenance.
- NP1184071.RAMFf5xy9ZWBD-OnabxBLbiK2uLuwBSuvmpNnhZvSj2SA130_assertion description "[LMO1 is a novel oncogene in colorectal cancer and its overexpression is a new predictive marker for anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1184071.RAMFf5xy9ZWBD-OnabxBLbiK2uLuwBSuvmpNnhZvSj2SA130_provenance.